Colipase-like protein 1, member of colipase family. Similar to CLPS and CLPSL2 with colipase domain structure. Putative lipase cofactor that may facilitate enzyme-substrate interactions for lipolytic enzymes in specific tissues. Expression pattern suggests tissue-specific or developmental role. Secreted protein functioning extracellularly. Function incompletely characterized but likely involved in lipid metabolism or digestion-related processes.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0008047
enzyme activator activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Enzyme activator activity - colipase cofactor function.
Reason: Putative core function.
Supporting Evidence:
file:human/CLPSL1/CLPSL1-deep-research-perplexity.md
See deep research file for comprehensive analysis
|
|
GO:0005576
extracellular region
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Extracellular region - secreted protein.
Reason: Core localization.
|
|
GO:0007586
digestion
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: Digestion - may function in digestive lipid processing.
Reason: KEEP_AS_NON_CORE
|
|
GO:0008047
enzyme activator activity
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: Enzyme activator activity - colipase cofactor function.
Reason: Putative core function.
|
|
GO:0016042
lipid catabolic process
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: Lipid catabolic process - lipolysis.
Reason: KEEP_AS_NON_CORE
|
Q: What lipase enzyme does CLPSL1 activate and in which physiological context?
Suggested experts: Lipid biochemists
Experiment: Lipase activity assays with recombinant CLPSL1
Hypothesis: CLPSL1 enhances lipase activity
Type: biochemical assay
CLPSL1 (Colipase-like protein 1), also known as C6orf127 or ESP32, is a protein-coding gene in humans located on chromosome 6p21.31 (UniProt accession A2RUU4). The protein belongs to the colipase family and contains a colipase domain (InterPro IPR001981), suggesting structural and potentially functional relationships to the well-characterized pancreatic colipase (CLPS). However, unlike the canonical colipase which serves as an essential cofactor for pancreatic lipase in dietary fat digestion, CLPSL1 appears to have evolved a specialized function in the male reproductive tract, with predominant expression in the epididymis.
Direct literature on CLPSL1 is extremely limited. According to PubMed searches, only one publication directly mentions CLPSL1 by name [li-2020-colorectal-biomarker-abstract], and this study identifies it merely as a biomarker in colorectal cancer without investigating its biological function. Therefore, understanding of CLPSL1 must be derived primarily from: (1) database annotations and expression data, (2) studies of its paralog CLPSL2, which shares structural features and epididymal expression, and (3) knowledge of the canonical colipase CLPS for comparative context.
Based on expression data from the Human Protein Atlas, CLPSL1 is classified as "group enriched" in the epididymis (572.6 nTPM) and pancreas (165.3 nTPM), with highest single-cell expression in epididymal principal cells (1,181.2 nCPM) and pancreatic acinar cells (347.3 nCPM) [human-protein-atlas-clpsl1]. The protein is predicted to be secreted and is annotated as "secreted in male reproductive system" with cytoplasmic expression detected by immunohistochemistry in epididymis tissue. These expression patterns suggest that CLPSL1, like its paralog CLPSL2, may function in sperm maturation during epididymal transit.
Colipase (CLPS) is a small protein (~10 kDa) that serves as an essential cofactor for pancreatic triglyceride lipase (PTL), enabling efficient dietary fat hydrolysis in the intestine. Structurally, colipase is characterized by a relatively flat architecture (approximately 25×30×35 Å) stabilized by five conserved disulfide bonds and limited secondary structure [vantilbeurgh-1999-colipase-structure-abstract]. The protein binds to the C-terminal, non-catalytic domain of pancreatic lipase, thereby stabilizing the enzyme's active conformation and creating a large hydrophobic binding surface that anchors the lipase-colipase complex at lipid-water interfaces [lowe-2002-triglyceride-lipases-abstract].
In the intestinal lumen, bile acids inhibit pancreatic lipase activity by displacing the enzyme from lipid droplet surfaces. Colipase counteracts this inhibition by acting as a molecular bridge: it binds to both the lipase and bile acids, anchoring the enzyme to the droplet surface and preventing its displacement. This functional relationship is critical for efficient dietary triglyceride digestion [kumar-2021-pancreatic-lipase-inhibitors-abstract].
Colipase is secreted as a precursor protein called procolipase, which is activated in the intestinal lumen by trypsin cleavage. This cleavage releases a pentapeptide from the N-terminus called enterostatin, which has independent signaling functions in regulating fat intake [erlanson-albertsson-1997-enterostatin-abstract]. The procolipase gene is upregulated by high-fat diets, and enterostatin acts as an anorectic signal that selectively reduces fat consumption.
The colipase domain (InterPro IPR001981) has been identified in several proteins beyond the canonical pancreatic colipase, including the colipase-like proteins CLPSL1 and CLPSL2 in humans. Interestingly, structural analogies have been recognized between colipase and domains in developmental proteins (such as Dickkopf), as well as domains in lipoxygenases and alpha-toxin that mediate membrane interactions [vantilbeurgh-1999-colipase-structure-abstract].
According to the Human Protein Atlas, CLPSL1 shows a distinctive tissue expression pattern that differs markedly from the canonical colipase CLPS, which is highly expressed in the pancreas for digestive function. CLPSL1 expression is highest in the epididymis (572.6 nTPM), with secondary expression in the pancreas (165.3 nTPM) and lower expression in salivary gland (1.4 nTPM), seminal vesicle (2.2 nTPM), and breast tissue (4.0 nTPM) [human-protein-atlas-clpsl1].
At the single-cell level, CLPSL1 is most highly expressed in epididymal principal cells (1,181.2 nCPM), which are the predominant epithelial cell type lining the epididymal duct and are responsible for secreting proteins into the luminal fluid that bathes maturing spermatozoa. CLPSL1 is also expressed in epididymal clear cells and basal cells, as well as pancreatic acinar cells (347.3 nCPM).
The tissue expression cluster for CLPSL1 is annotated as "Epididymis - Male reproductive secretion (mainly)," indicating that its primary biological role is likely related to male reproductive function rather than digestive lipase activation. The protein is predicted to be secreted, consistent with a role in the epididymal luminal environment where sperm maturation occurs.
Interestingly, CLPSL1 also shows some expression in the brain, particularly in the cerebral cortex (5.5 nTPM), hippocampal formation (4.0 nTPM), and other regions, with expression classified in the brain cluster "Neurons - Mixed function (mainly)" [human-protein-atlas-clpsl1]. The functional significance of this neural expression, if any, is unknown.
Given the scarcity of direct functional studies on CLPSL1, the most relevant functional insights come from studies of its paralog CLPSL2 (Colipase-like 2). CLPSL2 is also exclusively expressed in the epididymis, though specifically in the caput (head) region, whereas CLPSL1 is reported to be expressed in the corpus (body) region [genecards-clpsl1]. Both proteins belong to the colipase family and share structural features, suggesting potentially related or complementary functions.
According to PubMed, Lu et al. (2018) characterized CLPSL2 as a novel epididymis-specific secretory protein that is conserved across mammals. The protein is secreted into the epididymal lumen where it binds to the acrosome region and principal piece of the spermatozoa tail [lu-2018-clpsl2-epididymis-abstract]. Importantly, the study found that although CLPSL2 has the highest sequence identity with pancreatic colipase (CLPS), it lacks the conserved amino acid residues that are essential for lipase interaction. Consequently, recombinant CLPSL2 protein did not possess the classical colipase function of promoting lipase-mediated hydrolysis of glycerol trioleate. However, sequence analysis indicated that CLPSL2 retains the potential to bind lipids [lu-2018-clpsl2-epididymis-abstract].
Using lentivirus-mediated RNAi knockdown in vivo, Lu et al. reported that reduced CLPSL2 expression caused attenuation of sperm motility, suppressed acrosomal reaction, decreased cauda epididymal sperm numbers, and subfertility in mice. Based on these findings, the authors concluded that CLPSL2 is involved in the regulation of sperm motility, acrosomal integrity, and male fertility [lu-2018-clpsl2-epididymis-abstract].
However, these RNAi-based findings were subsequently challenged by Noda et al. (2019), who generated complete CLPSL2 knockout mice using CRISPR/Cas9 gene editing [noda-2019-nine-genes-dispensable-abstract]. Strikingly, the Clpsl2 knockout males showed completely normal fertility, with litter sizes statistically indistinguishable from wild-type controls (9.8 ± 0.8 for controls vs. 9.1 ± 0.5 for Clpsl2 KO; p = 0.20). No apparent differences were observed in epididymal histology or sperm morphology between knockout and control animals. The authors suggested that the discrepancy between the RNAi and knockout results may be due to off-target effects of the RNAi approach [noda-2019-nine-genes-dispensable-abstract].
These findings for CLPSL2 suggest that while colipase-like proteins may bind to sperm and potentially contribute to some aspect of sperm maturation or function, they are not individually essential for male fertility, at least in mice. It remains possible that CLPSL1 and CLPSL2 have redundant functions, and that loss of one can be compensated by the other or by additional mechanisms.
CLPSL1 is predicted to be both a secreted protein and to have intracellular localization, with different isoforms potentially showing different distributions [human-protein-atlas-clpsl1]. The gene produces two protein-coding transcripts, and both secreted and intracellular forms are predicted.
The extracellular/secreted form is annotated as being "secreted in male reproductive system," consistent with a role in the epididymal lumen. Immunohistochemistry shows cytoplasmic expression in the epididymis. Given that epididymal principal cells actively secrete numerous proteins into the luminal fluid that interacts with maturing spermatozoa, CLPSL1 secretion into this compartment would position it to interact with sperm or regulate the luminal microenvironment.
Gene Ontology (GO) annotations for CLPSL1 include:
Molecular Function:
- Enzyme activator activity (GO:0008047)
Biological Process:
- Digestion (GO:0007586)
- Lipid catabolic process (GO:0016042)
- Response to food (GO:0032094)
These annotations appear to be inferred from the colipase domain and homology to the canonical colipase rather than from direct experimental evidence. The "enzyme activator activity" annotation reflects the known function of colipase as a cofactor that activates pancreatic lipase. However, as noted from studies of CLPSL2, the colipase-like proteins may lack the specific residues required for lipase activation, so these functional annotations may not accurately reflect CLPSL1's actual biological role [lu-2018-clpsl2-epididymis-abstract].
The only published study that directly mentions CLPSL1 is a bioinformatics analysis by Li et al. (2020) that identified a four-mRNA signature associated with lymphatic metastasis for prognosis of colorectal cancer [li-2020-colorectal-biomarker-abstract]. In this study, CLPSL1 was identified along with EPHA8, KRT85, and GABRA3 as independent prognostic indicators for colorectal cancer.
The authors found that 329 mRNAs were upregulated in colorectal cancer tissues with lymph node metastasis, and CLPSL1 was among the genes in this set. However, the study did not investigate the biological function of CLPSL1 in cancer or provide mechanistic insights into why CLPSL1 expression might be associated with metastatic progression. The finding may reflect aberrant expression of tissue-specific genes in cancer cells (ectopic expression) rather than a functional role in tumorigenesis.
According to the Human Protein Atlas cancer expression data, moderate to strong cytoplasmic staining for CLPSL1 has been detected in renal cancer cases, while other cancer types show weak or negative staining [human-protein-atlas-clpsl1].
The three members of the colipase family in humans (CLPS, CLPSL1, and CLPSL2) show distinct expression patterns and likely have divergent functions despite their shared domain structure:
| Feature | CLPS (Colipase) | CLPSL1 | CLPSL2 |
|---|---|---|---|
| Primary tissue | Pancreas | Epididymis (corpus) | Epididymis (caput) |
| Known function | Lipase cofactor | Unknown | Unknown |
| Lipase activation | Yes | Likely not | No |
| Essential for fertility | N/A | Unknown | No (in mice) |
| Lipid binding potential | Yes | Predicted | Yes |
This pattern suggests that the colipase-like proteins have been co-opted during evolution from their ancestral role in digestive fat hydrolysis to serve specialized functions in the male reproductive tract. The retention of lipid-binding potential without lipase activation capability suggests that these proteins may interact with membrane lipids or lipid-associated molecules on sperm surfaces.
According to BioGRID, CLPSL1 has 46 documented interactors and 59 total interactions [biogrid-clpsl1]. These interaction data are likely derived from high-throughput screens rather than targeted studies, and the biological relevance of individual interactions remains to be validated. The nature of these interactions and whether they relate to CLPSL1's function in the reproductive tract is unknown.
The epididymis plays a critical role in post-testicular sperm maturation, providing the microenvironment necessary for spermatozoa to gain progressive motility and fertilization capacity. During transit through the epididymis, the sperm plasma membrane undergoes extensive remodeling, with significant changes in phospholipid composition and cholesterol content [cornwall-2009-epididymis-review]. This membrane remodeling is essential for proper sperm function, as cholesterol removal from the sperm membrane is one of the first steps triggering signal transduction cascades during capacitation.
Several secreted proteins in the epididymis have been shown to participate in lipid-related processes during sperm maturation. For example, Group III secreted phospholipase A2 (sPLA2-III), expressed in the proximal epididymal epithelium, is essential for proper sperm maturation and fertility in mice [shida-2008-spla2-iii]. During epididymal transit, this enzyme facilitates dramatic remodeling of sperm membrane phospholipids, shifting the fatty acid composition toward more unsaturated species (docosapentaenoic and docosahexaenoic acids) that enhance membrane fluidity. Knockout of sPLA2-III leads to compromised lipid remodeling and male infertility.
Lipid rafts, specialized membrane microdomains enriched in cholesterol and sphingolipids, have been described in spermatozoa from multiple species including humans. These rafts serve as signaling platforms that reorganize during capacitation, concentrating key proteins required for fertilization [cornwall-2009-epididymis-review]. Epididymosomes, extracellular vesicles secreted by the epididymal epithelium, also transfer proteins and lipids to maturing spermatozoa through membrane fusion.
Given this biological context, CLPSL1's expression pattern and predicted lipid-binding capacity (based on its colipase domain) are consistent with a potential role in the lipid-related aspects of sperm maturation. However, unlike sPLA2-III which has direct enzymatic activity, CLPSL1 appears to lack the residues required for lipase activation (based on studies of CLPSL2), suggesting it may function through direct lipid binding or protein-protein interactions rather than enzymatic catalysis. The exact nature of CLPSL1's contribution to epididymal lipid metabolism, if any, remains to be determined experimentally.
CLPSL1 is conserved across mammals, with orthologs identified in 34 organisms according to GeneCards. The conservation of both CLPSL1 and CLPSL2 across mammalian species suggests that these genes serve biologically important functions, even if loss of individual family members is tolerated for fertility in mice. The presence of two colipase-like paralogs specifically expressed in different regions of the epididymis (CLPSL1 in corpus, CLPSL2 in caput) suggests that they may have complementary or partially redundant roles in sperm maturation.
Despite the available annotation and expression data, numerous fundamental questions about CLPSL1 remain unanswered:
Molecular function: Does CLPSL1 retain any capacity to activate lipases, or has it completely lost this ancestral function? What is its precise molecular function in the epididymis?
Substrate specificity: If CLPSL1 binds lipids, what are its preferred lipid substrates? Does it interact with specific membrane components of spermatozoa?
Sperm interaction: Does CLPSL1, like CLPSL2, bind to specific regions of spermatozoa? If so, what is the functional consequence of this binding?
Genetic redundancy: Do CLPSL1 and CLPSL2 have redundant functions that would only be revealed in double-knockout animals?
Human fertility: Is CLPSL1 expression or function altered in cases of human male infertility? Are there genetic variants associated with reproductive disorders?
Signaling role: Does CLPSL1, like procolipase/enterostatin, have signaling functions beyond its structural role?
Cancer association: Why is CLPSL1 upregulated in colorectal cancer with lymph node metastasis? Is this functionally significant or merely a consequence of aberrant gene expression in cancer cells?
Brain expression: What is the functional significance, if any, of CLPSL1 expression in neurons?
These questions would require targeted experimental studies including generation of CLPSL1 knockout mice (and ideally CLPSL1/CLPSL2 double knockouts), biochemical characterization of recombinant CLPSL1 protein, and identification of interacting proteins and lipids in the epididymal context.
li-2020-colorectal-biomarker-abstract: Li X, Zhang Q, Zhao L, et al. A Combined four-mRNA Signature Associated with Lymphatic Metastasis for Prognosis of Colorectal Cancer. J Cancer. 2020;11(8):2139-2149. PMID: 32127941. DOI: 10.7150/jca.38796
lu-2018-clpsl2-epididymis-abstract: Lu X, Ding F, Lian Z, et al. An epididymis-specific secretory protein Clpsl2 critically regulates sperm motility, acrosomal integrity, and male fertility. J Cell Biochem. 2018;119(6):4760-4774. PMID: 29323738. DOI: 10.1002/jcb.26668
noda-2019-nine-genes-dispensable-abstract: Noda T, Sakurai N, Nozawa K, et al. Nine genes abundantly expressed in the epididymis are not essential for male fecundity in mice. Andrology. 2019;7(5):644-653. PMID: 30927342. PMCID: PMC6688925. DOI: 10.1111/andr.12621
robertson-2020-reproductive-tract-genes-abstract: Robertson MJ, Kent K, Tharp N, et al. Large-scale discovery of male reproductive tract-specific genes through analysis of RNA-seq datasets. BMC Biol. 2020;18(1):103. PMID: 32814578. PMCID: PMC7436996. DOI: 10.1186/s12915-020-00826-z
vantilbeurgh-1999-colipase-structure-abstract: van Tilbeurgh H, Bezzine S, Cambillau C, Verger R, Carrière F. Colipase: structure and interaction with pancreatic lipase. Biochim Biophys Acta. 1999;1441(2-3):173-84. PMID: 10570245. DOI: 10.1016/s1388-1981(99)00149-3
lowe-2002-triglyceride-lipases-abstract: Lowe ME. The triglyceride lipases of the pancreas. J Lipid Res. 2002;43(12):2007-16. PMID: 12454260. DOI: 10.1194/jlr.r200012-jlr200
erlanson-albertsson-1997-enterostatin-abstract: Erlanson-Albertsson C, York D. Enterostatin--a peptide regulating fat intake. Obes Res. 1997;5(4):360-72. PMID: 9285845. DOI: 10.1002/j.1550-8528.1997.tb00565.x
kumar-2021-pancreatic-lipase-inhibitors-abstract: Kumar A, Chauhan S. Pancreatic lipase inhibitors: The road voyaged and successes. Life Sci. 2021;271:119115. PMID: 33515565. DOI: 10.1016/j.lfs.2021.119115
human-protein-atlas-clpsl1: Human Protein Atlas - CLPSL1. https://www.proteinatlas.org/ENSG00000204140-CLPSL1
genecards-clpsl1: GeneCards - CLPSL1 Gene. https://www.genecards.org/cgi-bin/carddisp.pl?gene=CLPSL1
biogrid-clpsl1: BioGRID - CLPSL1 Interactions. https://thebiogrid.org/131012/table/homo-sapiens/clpsl1.html
cornwall-2009-epididymis-review: Cornwall GA. New insights into epididymal biology and function. Hum Reprod Update. 2009;15(2):213-227. PMCID: PMC2639084. https://pmc.ncbi.nlm.nih.gov/articles/PMC2639084/
shida-2008-spla2-iii: Sato H, et al. Group III secreted phospholipase A2 regulates epididymal sperm maturation and fertility in mice. J Biol Chem. 2010;285(17):12224-12232. PMCID: PMC2860917. https://pmc.ncbi.nlm.nih.gov/articles/PMC2860917/
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Plan overview
We first verified the gene/protein identity for human CLPSL1 (C6orf127; UniProt A2RUU4) and assessed possible symbol ambiguity. We then gathered evidence on expression, localization, family/domain context, computational/functional inference, disease associations, CNV/evolutionary context, and proteome catalog status. Given the sparse direct literature on CLPSL1, we prioritized authoritative proteomics and population-genomics sources and highlighted limitations.
Key concepts and definitions
- Identity and family: CLPSL1 encodes a colipase-like protein (a paralog of the pancreatic colipase CLPS). In population-genomics context, CLPSL1 is grouped with genes involved in lipid digestion and transport and treated as “Colipase Like 1” (paralog of CLPS) (bioRxiv 2021) (vicedomini2021geneticdietaryadaptation pages 6-7). The colipase family consists of small secreted proteins that act as cofactors for pancreatic lipase to facilitate triglyceride hydrolysis; CLPSL1 is considered colipase-like by homology and paralogy to CLPS in humans (bioRxiv 2021) (vicedomini2021geneticdietaryadaptation pages 6-7).
- Protein existence and localization: Enhanced Human Protein Atlas (HPA) antibody-validation indicates CLPSL1 protein detection in human tissue; immunohistochemistry (IHC) shows cytoplasmic staining in glandular cells of the epididymis (Journal of Proteome Research, 2020) (sivertsson2020enhancedvalidationof pages 9-11).
- Proteome catalog status: CLPSL1 has been cataloged among “missing proteins” in proteome surveys, including the HPA-validated cohort and studies targeting human spermatozoa proteomes (JPR 2016; JPR 2020) (vandenbrouck2016lookingformissing pages 39-40, sivertsson2020enhancedvalidationof pages 9-11).
Recent developments and latest research (prioritizing 2023–2024)
- Direct, gene-specific publications for CLPSL1 remain scarce in 2023–2024 among the retrieved texts. The most directly informative, recent evidence is from enhanced antibody validation that confirmed protein detection and a broader population-genomics preprint linking CLPSL1 to lipid-digestion gene sets and CNV trends (2020 and 2021, respectively). No 2023–2024 CLPSL1 mechanistic papers were retrieved in this search scope; this reflects the gene’s continuing status as a poorly characterized or “missing” protein in many resources (sivertsson2020enhancedvalidationof pages 9-11, vandenbrouck2016lookingformissing pages 39-40, vicedomini2021geneticdietaryadaptation pages 6-7, vicedomini2021geneticdietaryadaptation pages 9-12).
Current applications and real-world implementations
- Antibody-based proteomics and protein existence pipelines: CLPSL1 was included in rigorous HPA antibody validation to substantiate protein existence and tissue localization. This is a real-world pipeline for curating previously unvalidated human proteins (JPR 2020) (sivertsson2020enhancedvalidationof pages 9-11).
- Biomarker signatures in oncology: CLPSL1 mRNA appears in a four-gene prognostic signature (EPHA8, CLPSL1, KRT85, GABRA3) associated with lymph node metastasis (LNM) and poorer prognosis in colorectal cancer (Journal of Cancer 2020). The combined signature achieved an AUC of 0.730 and stratified risk across multiple clinical subgroups (li2020acombinedfourmrna pages 9-10, li2020acombinedfourmrna pages 6-9).
Expert opinions and analysis from authoritative sources
- Proteome experts emphasize the need for orthogonal antibody validation for proteins of uncertain existence. In this framework, CLPSL1 was validated with IHC showing epididymis cytoplasmic staining in glandular cells, supporting protein existence and a specific tissue signal (JPR 2020) (sivertsson2020enhancedvalidationof pages 9-11).
- Population-genomics analysis interprets CLPSL1 within a lipid digestion/transport gene cohort and reports positive CNV trends for CLPS/CLPSL1 in Neandertals (Hn), suggesting evolutionary modulation of lipid-metabolic components. The authors’ digestion/metabolism panel is “principally expressed in digestive organs,” consistent with the colipase-like identity (bioRxiv 2021) (vicedomini2021geneticdietaryadaptation pages 3-4, vicedomini2021geneticdietaryadaptation pages 6-7, vicedomini2021geneticdietaryadaptation pages 9-12).
Relevant statistics and data from recent studies
- Tissue localization by IHC: epididymis, cytoplasm of glandular cells (JPR 2020; enhanced HPA validation) (sivertsson2020enhancedvalidationof pages 9-11).
- CRC biomarker performance: four-mRNA signature including CLPSL1 had AUC = 0.730 for prognosis and was independently prognostic in subgroups; CLPSL1 expression was higher in LNM vs. non-LNM (p < 0.05) (Journal of Cancer 2020) (li2020acombinedfourmrna pages 9-10, li2020acombinedfourmrna pages 6-9).
- Evolutionary CNV trends: positive CNV trend for CLPSL1 (and CLPS) reported in Neandertals; panel framed as digestion/lipid metabolism-related genes (bioRxiv 2021) (vicedomini2021geneticdietaryadaptation pages 6-7, vicedomini2021geneticdietaryadaptation pages 9-12).
Embedded evidence summary table
| Aspect | Evidence summary | Source (URL, date) | Context ID |
|---|---|---|---|
| Localization; proteome catalog status | Antibody-validated detection via enhanced HPA validation; IHC shows cytoplasmic staining in epididymis glandular cells; CLPSL1 treated as a "missing protein" validated by orthogonal antibody strategy. | Sivertsson Å, Lindström E, Oksvold P, et al. Enhanced Validation of Antibodies Enables the Discovery of Missing Proteins. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.0c00486 (Nov 2020). | (sivertsson2020enhancedvalidationof pages 9-11) |
| Expression; disease associations / biomarker | Identified as one of a four-mRNA prognostic signature (EPHA8, CLPSL1, KRT85, GABRA3) for lymph node metastasis in colorectal cancer; CLPSL1 expression higher in LNM (p < 0.05); combined signature AUC = 0.730 and associated with poorer prognosis. | Li X, Zhang Q, Zhao L, et al. A Combined four-mRNA Signature Associated with Lymphatic Metastasis for Prognosis of Colorectal Cancer. Journal of Cancer. https://doi.org/10.7150/jca.38796 (Feb 2020). | (li2020acombinedfourmrna pages 9-10) |
| Proteome catalog status (sperm proteome) | Listed among candidate "missing proteins" in an updated proteomic survey of human spermatozoa; included in a compiled list but without additional functional characterization. | Vandenbrouck Y, Lane L, Carapito C, et al. Looking for Missing Proteins in the Proteome of Human Spermatozoa: An Update. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.6b00400 (Aug 2016). | (vandenbrouck2016lookingformissing pages 39-40) |
| Identity/family; copy number / evolution; expression inference | Described as "Colipase Like 1" (paralog of CLPS) and grouped with genes involved in lipid digestion/transport; reported positive CNV trend for CLPS and CLPSL1 in Neandertals (Hn) and included in an 11-gene digestion/metabolism panel said to be principally expressed in digestive organs. (bioRxiv preprint) | Vicedomini R, Righetti N, Polit L, et al. Genetic dietary adaptation in Neandertal, Denisovan and Sapiens revealed by gene copy number variation. bioRxiv. https://doi.org/10.1101/2021.10.30.466563 (version posted Nov 2, 2021). | (vicedomini2021geneticdietaryadaptation pages 12-14, vicedomini2021geneticdietaryadaptation pages 6-7, vicedomini2021geneticdietaryadaptation pages 9-12) |
Table: A concise table summarizing published evidence for human CLPSL1 (C6orf127; UniProt A2RUU4), linking identity/family, expression, localization, CNV/evolution, and proteome catalog status to source citations and context IDs for verification.
Functional annotation synthesis for CLPSL1
- Family/domain and predicted function: By homology, CLPSL1 belongs to the colipase-related family and is a paralog of CLPS in humans. Colipases are secreted cofactors that position and stabilize pancreatic lipase at the lipid–water interface, enhancing triglyceride hydrolysis—a core step in dietary fat digestion. Population-genomics categorization places CLPSL1 in a lipid digestion/transport cohort, consistent with a colipase-like identity (bioRxiv 2021) (vicedomini2021geneticdietaryadaptation pages 6-7, vicedomini2021geneticdietaryadaptation pages 9-12). Direct biochemical activity or substrate-specificity data for human CLPSL1 are not available in the retrieved sources; thus, function is inferred from family/domain context rather than experimentally demonstrated for CLPSL1.
- Localization and compartment: Antibody-validated HPA/IHC indicates cytoplasmic staining in epididymis glandular cells, supporting protein existence and a specific tissue signal. No direct secretory pathway evidence for CLPSL1 was shown in the retrieved texts; however, colipases are classically secreted pancreatic proteins. In the absence of CLPSL1-specific secretion data, the subcellular site of action remains unproven for CLPSL1 (JPR 2020; family-informed inference) (sivertsson2020enhancedvalidationof pages 9-11).
- Expression profile: The HPA antibody-validation paper provides tissue-level localization for CLPSL1 (epididymis). The population-genomics preprint places CLPSL1 in a set “principally expressed in digestive organs,” consistent with the digestive role inferred by homology, although explicit HPA-based digestive expression statements for CLPSL1 were not present in the quoted passages (bioRxiv 2021; JPR 2020) (vicedomini2021geneticdietaryadaptation pages 3-4, sivertsson2020enhancedvalidationof pages 9-11).
- Disease and biomarker context: CLPSL1 mRNA participates in a four-gene signature associated with lymphatic metastasis and prognosis in colorectal cancer; higher CLPSL1 expression correlates with LNM. The signature, rather than CLPSL1 alone, provides prognostic performance (AUC 0.730). Mechanistic roles of CLPSL1 in CRC metastasis were not established and require follow-up (Journal of Cancer 2020) (li2020acombinedfourmrna pages 9-10, li2020acombinedfourmrna pages 6-9).
- Evolutionary and CNV context: Positive CNV trends for CLPS/CLPSL1 in Neandertals suggest selection on lipid digestion pathways in archaic human populations. The same work frames an 11-gene digestion/metabolism panel including CLPSL1, reinforcing the lipid-digestion inference (bioRxiv 2021) (vicedomini2021geneticdietaryadaptation pages 6-7, vicedomini2021geneticdietaryadaptation pages 9-12).
- Proteome status and evidence quality: Independent lines of proteomics evidence have considered CLPSL1 a “missing protein.” Antibody-based validation now supports existence in human tissue (epididymis), but broad functional characterization remains limited (JPR 2016; JPR 2020) (vandenbrouck2016lookingformissing pages 39-40, sivertsson2020enhancedvalidationof pages 9-11).
Critical verification per user instructions
1) Gene symbol match: CLPSL1 is explicitly referred to as “colipase like 1” and paralogous to CLPS in the population-genomics source, consistent with the UniProt description provided (vicedomini2021geneticdietaryadaptation pages 6-7).
2) Organism: All cited evidence pertains to human datasets or human tissue proteomics (sivertsson2020enhancedvalidationof pages 9-11, li2020acombinedfourmrna pages 9-10, vandenbrouck2016lookingformissing pages 39-40, vicedomini2021geneticdietaryadaptation pages 6-7).
3) Family/domain: Sources group CLPSL1 with colipase/lipid digestion genes, consistent with the colipase domain family context in the UniProt metadata (vicedomini2021geneticdietaryadaptation pages 6-7, vicedomini2021geneticdietaryadaptation pages 9-12).
4) Ambiguity: No conflicting genes with the CLPSL1 symbol were found in the retrieved literature. Nonetheless, literature remains sparse, so interpretations rely partly on family/domain inference and curated proteomics pipelines.
Limitations and open questions
- Direct biochemical assays for CLPSL1 activity, substrate specificity, and cofactors in human tissues are lacking in the retrieved texts.
- Comprehensive tissue expression and secretion pathway data specific to CLPSL1 were not identified here; digestive expression and secretory behavior are inferred from paralogy and panel membership rather than shown experimentally for CLPSL1.
- Oncology associations to date come from multigene signatures; CLPSL1’s individual causal role remains to be established.
References with URLs and dates
- Sivertsson Å, Lindström E, Oksvold P, et al. Enhanced Validation of Antibodies Enables the Discovery of Missing Proteins. Journal of Proteome Research. Published Nov 2020. URL: https://doi.org/10.1021/acs.jproteome.0c00486 (sivertsson2020enhancedvalidationof pages 9-11).
- Li X, Zhang Q, Zhao L, et al. A Combined four-mRNA Signature Associated with Lymphatic Metastasis for Prognosis of Colorectal Cancer. Journal of Cancer. Published Feb 2020. URL: https://doi.org/10.7150/jca.38796 (li2020acombinedfourmrna pages 9-10, li2020acombinedfourmrna pages 6-9).
- Vandenbrouck Y, Lane L, Carapito C, et al. Looking for Missing Proteins in the Proteome of Human Spermatozoa: An Update. Journal of Proteome Research. Published Aug 2016. URL: https://doi.org/10.1021/acs.jproteome.6b00400 (vandenbrouck2016lookingformissing pages 39-40).
- Vicedomini R, Righetti N, Polit L, et al. Genetic dietary adaptation in Neandertal, Denisovan and Sapiens revealed by gene copy number variation. bioRxiv preprint. Version posted Nov 2, 2021. URL: https://doi.org/10.1101/2021.10.30.466563 (vicedomini2021geneticdietaryadaptation pages 12-14, vicedomini2021geneticdietaryadaptation pages 6-7, vicedomini2021geneticdietaryadaptation pages 3-4, vicedomini2021geneticdietaryadaptation pages 9-12).
References
(vicedomini2021geneticdietaryadaptation pages 6-7): Riccardo Vicedomini, Niccolò Righetti, Lélia Polit, Silvana Condemi, Laura Longo, and Alessandra Carbone. Genetic dietary adaptation in neandertal, denisovan and sapiens revealed by gene copy number variation. bioRxiv, Nov 2021. URL: https://doi.org/10.1101/2021.10.30.466563, doi:10.1101/2021.10.30.466563. This article has 2 citations and is from a poor quality or predatory journal.
(sivertsson2020enhancedvalidationof pages 9-11): Åsa Sivertsson, Emil Lindström, Per Oksvold, Borbala Katona, Feria Hikmet, Jimmy Vuu, Jonas Gustavsson, Evelina Sjöstedt, Kalle von Feilitzen, Caroline Kampf, Jochen M. Schwenk, Mathias Uhlén, and Cecilia Lindskog. Enhanced validation of antibodies enables the discovery of missing proteins. Journal of Proteome Research, 19:4766-4781, Nov 2020. URL: https://doi.org/10.1021/acs.jproteome.0c00486, doi:10.1021/acs.jproteome.0c00486. This article has 27 citations and is from a peer-reviewed journal.
(vandenbrouck2016lookingformissing pages 39-40): Yves Vandenbrouck, Lydie Lane, Christine Carapito, Paula Duek, Karine Rondel, Christophe Bruley, Charlotte Macron, Anne Gonzalez de Peredo, Yohann Couté, Karima Chaoui, Emmanuelle Com, Alain Gateau, Anne-Marie Hesse, Marlene Marcellin, Loren Méar, Emmanuelle Mouton-Barbosa, Thibault Robin, Odile Burlet-Schiltz, Sarah Cianferani, Myriam Ferro, Thomas Fréour, Cecilia Lindskog, Jérôme Garin, and Charles Pineau. Looking for missing proteins in the proteome of human spermatozoa: an update. Journal of proteome research, 15 11:3998-4019, Aug 2016. URL: https://doi.org/10.1021/acs.jproteome.6b00400, doi:10.1021/acs.jproteome.6b00400. This article has 84 citations and is from a peer-reviewed journal.
(vicedomini2021geneticdietaryadaptation pages 9-12): Riccardo Vicedomini, Niccolò Righetti, Lélia Polit, Silvana Condemi, Laura Longo, and Alessandra Carbone. Genetic dietary adaptation in neandertal, denisovan and sapiens revealed by gene copy number variation. bioRxiv, Nov 2021. URL: https://doi.org/10.1101/2021.10.30.466563, doi:10.1101/2021.10.30.466563. This article has 2 citations and is from a poor quality or predatory journal.
(li2020acombinedfourmrna pages 9-10): Xueping Li, Qiang Zhang, Lan Zhao, Longyang Jiang, Aoshuang Qi, Qian Wei, Xinyue Song, Lin Wang, Liwen Zhang, Yanyun Zhao, Xuemei Lv, Minjie Wei, and Lin Zhao. A combined four-mrna signature associated with lymphatic metastasis for prognosis of colorectal cancer. Journal of Cancer, 11:2139-2149, Feb 2020. URL: https://doi.org/10.7150/jca.38796, doi:10.7150/jca.38796. This article has 15 citations and is from a peer-reviewed journal.
(li2020acombinedfourmrna pages 6-9): Xueping Li, Qiang Zhang, Lan Zhao, Longyang Jiang, Aoshuang Qi, Qian Wei, Xinyue Song, Lin Wang, Liwen Zhang, Yanyun Zhao, Xuemei Lv, Minjie Wei, and Lin Zhao. A combined four-mrna signature associated with lymphatic metastasis for prognosis of colorectal cancer. Journal of Cancer, 11:2139-2149, Feb 2020. URL: https://doi.org/10.7150/jca.38796, doi:10.7150/jca.38796. This article has 15 citations and is from a peer-reviewed journal.
(vicedomini2021geneticdietaryadaptation pages 3-4): Riccardo Vicedomini, Niccolò Righetti, Lélia Polit, Silvana Condemi, Laura Longo, and Alessandra Carbone. Genetic dietary adaptation in neandertal, denisovan and sapiens revealed by gene copy number variation. bioRxiv, Nov 2021. URL: https://doi.org/10.1101/2021.10.30.466563, doi:10.1101/2021.10.30.466563. This article has 2 citations and is from a poor quality or predatory journal.
(vicedomini2021geneticdietaryadaptation pages 12-14): Riccardo Vicedomini, Niccolò Righetti, Lélia Polit, Silvana Condemi, Laura Longo, and Alessandra Carbone. Genetic dietary adaptation in neandertal, denisovan and sapiens revealed by gene copy number variation. bioRxiv, Nov 2021. URL: https://doi.org/10.1101/2021.10.30.466563, doi:10.1101/2021.10.30.466563. This article has 2 citations and is from a poor quality or predatory journal.
CLPSL1 (Colipase-Like 1) is a human gene encoding a small secreted protein that closely resembles pancreatic colipase in sequence and domain structure (www.cloud-clone.com). Colipases are cofactors required for digestive lipase enzymes, and CLPSL1 is predicted to function as an enzyme activator in a similar capacity (www.ncbi.nlm.nih.gov). Like the canonical colipase (product of the CLPS gene), CLPSL1 is synthesized as a precursor (preproprotein) that includes an N-terminal signal peptide and an activation peptide. Upon secretion into the digestive tract or other luminal spaces, the precursor is cleaved by trypsin to release a short pentapeptide and the mature colipase-like domain (pmc.ncbi.nlm.nih.gov). (In pancreatic colipase, this pentapeptide is known as enterostatin, which has been implicated in satiety signaling (pmc.ncbi.nlm.nih.gov). By analogy, CLPSL1 likely produces a similar peptide, though its specific bioactivity has not been studied.) The mature CLPSL1 protein is only about 90–100 amino acids in length (∼10 kDa) and belongs to the colipase family, characterized by a conserved disulfide-rich fold (www.cloud-clone.com). These structural features suggest CLPSL1 can assume the same architectural functionality as colipase, i.e. a compact, stable cofactor capable of binding lipases and lipid micelles (pubmed.ncbi.nlm.nih.gov). Current genomic annotations (Alliance of Genome Resources, 2025) classify CLPSL1 as a secreted protein cofactor with enzyme activator activity, involved in nutrient response (www.ncbi.nlm.nih.gov), consistent with its homology to colipase. Notably, the CLPSL1 gene is located on chromosome 6p21.31 in close proximity to the pancreatic colipase gene, indicating it arose from a gene duplication in this region (www.ncbi.nlm.nih.gov). To date, CLPSL1 remains less characterized in the literature; however, protein-level evidence confirms its existence and supports a role analogous to pancreatic colipase (www.proteinatlas.org).
The primary function of Colipase-like 1 is inferred from its high similarity to pancreatic colipase (CLPS). Pancreatic colipase is a well-studied cofactor for pancreatic triglyceride lipase, essential for efficient dietary fat digestion (pubmed.ncbi.nlm.nih.gov). Colipase itself does not catalyze lipid hydrolysis; instead, it binds both to the lipase enzyme and to the lipid-water interface (e.g. emulsified dietary triglycerides), thereby anchoring and stabilizing the lipase at the lipid droplet surface (www.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). In the intestinal lumen, bile salts present in digestive juices can displace lipase from fat droplets, inhibiting lipase activity. Colipase resolves this problem by serving as a bridge: one face of colipase binds tightly to the C-terminal, non-catalytic domain of pancreatic lipase, while the opposite face binds to the bile-salt–covered lipid micelle (pubmed.ncbi.nlm.nih.gov). This interaction stabilizes an active conformation of the lipase and greatly increases the effective hydrophobic binding site, overcoming bile salt inhibition (pubmed.ncbi.nlm.nih.gov). Without colipase, pancreatic lipase is washed off the lipid interface by bile, drastically reducing fat breakdown (pmc.ncbi.nlm.nih.gov). Given that CLPSL1 contains the same conserved COLIPASE domain (including key cysteine residues for the colipase fold) (www.ncbi.nlm.nih.gov), it is presumed to perform an analogous molecular function. In other words, CLPSL1 likely acts as an enzyme activator that binds lipases, promoting their attachment to triglyceride substrates and restoring activity in the presence of bile acids (pmc.ncbi.nlm.nih.gov). The substrates in this context are the dietary lipids (triacylglycerols) being hydrolyzed and the enzymes are pancreatic lipases; CLPSL1 itself serves as a required cofactor rather than an enzyme.
Importantly, experimental characterization of CLPSL1’s biochemical activity is limited, so this functional assignment is based primarily on homology and bioinformatic prediction. No unique catalytic activity or alternative binding partners for CLPSL1 have been reported in literature as of 2023. However, large-scale proteomic interaction studies have detected CLPSL1 in complex with other proteins, suggesting it is expressed and folds properly in cells (thebiogrid.org). (For instance, CLPSL1 was identified in affinity-purification mass spectrometry screens of the human proteome, although its specific interacting partners in those experiments – such as TNFAIP1 – may reflect intracellular context or experimental artifacts (thebiogrid.org).) Overall, the consensus expert opinion is that CLPSL1 likely functions as a colipase paralog, fulfilling a similar cofactor role for pancreatic lipase or related enzymes (pmc.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). Any subtle differences in substrate or enzyme specificity between CLPSL1 and classical colipase remain to be determined.
Given its inferred role as a lipid digestion cofactor, CLPSL1 is believed to participate in digestive processes, particularly the dietary fat digestion and absorption pathway. In the exocrine pancreas, CLPSL1 would be secreted alongside pancreatic enzymes into the duodenum. There, it would function in concert with pancreatic triglyceride lipase (PNLIP) and bile salts to enable the breakdown of triglycerides into fatty acids and monoglycerides (pmc.ncbi.nlm.nih.gov). This places CLPSL1 in the same pathway context as colipase – namely, the intestinal phase of lipid digestion. Key processes include emulsification of fats by bile, lipase-colipase binding to the micelle, and subsequent hydrolysis of fats. By anchoring lipases at the lipid interface, colipase family proteins are essential for efficient lipid nutrient absorption (pmc.ncbi.nlm.nih.gov). Consistent with this, gene ontology annotations (updated 2025) associate CLPSL1 with “response to food” (www.ncbi.nlm.nih.gov). This term likely reflects the fact that expression of digestive cofactors like colipase is nutritionally regulated – for example, pancreatic colipase levels rise with high-fat feeding, and its activation peptide (enterostatin) acts as a feedback signal to modulate fat intake (pmc.ncbi.nlm.nih.gov). While CLPSL1’s regulation has not been specifically examined, the annotation suggests it may be co-regulated with dietary intake or feeding signals in a similar manner. Indeed, enterostatin (the cleaved product of procolipase) was shown to suppress fat consumption in animal models (pmc.ncbi.nlm.nih.gov), highlighting how the colipase system links digestion to satiety and nutritional homeostasis. If CLPSL1 produces an analogous peptide upon activation, it could conceivably partake in such gut-brain signaling, though this remains speculative without direct evidence.
Outside of the digestive tract, CLPSL1 might have a more localized physiological role. Notably, this gene is expressed in the male reproductive tract (epididymis), where its function is less clear (see below). The epididymis is known to secrete many proteins that modify sperm and the luminal environment; CLPSL1’s presence there hints it could be involved in lipid modification or signaling in seminal fluids. For example, it might interact with lipids or lipases in the epididymal fluid, potentially influencing sperm membrane composition or providing nutritional support to maturing sperm. However, no specific epididymal substrate or pathway for CLPSL1 has been identified so far. Therefore, the best-understood context for CLPSL1’s activity is still the pancreatic digestive enzyme pathway, paralleling colipase in facilitating lipid breakdown in the small intestine (pmc.ncbi.nlm.nih.gov). Future studies (e.g. targeted knockout or biochemical assays) would be needed to confirm this role and to explore any additional pathways where CLPSL1 may be active.
Tissue distribution of CLPSL1 is distinctive: it is most highly expressed in the pancreas and the epididymis, with relatively lower expression in other tissues. Transcriptomic and proteomic data classify CLPSL1 as “group enriched” in pancreas and epididymis (www.proteinatlas.org). Specifically, RNA-seq analyses (GTEx and HPA datasets) show that CLPSL1 mRNA is abundant in pancreatic tissue (especially the exocrine pancreas) and in the epididymal epithelium, whereas most other organs have only minimal levels (www.proteinatlas.org). This expression pattern aligns with the gene’s proposed function in secretory processes. In the pancreas, acinar cells (the exocrine cells that produce digestive enzymes) are the likely source of CLPSL1. Recent single-cell RNA sequencing data place CLPSL1 in a cluster of pancreatic exocrine cell genes associated with proteolytic digestion (www.proteinatlas.org). In the epididymis, CLPSL1 appears to be produced by the epithelial principal cells that line the epididymal duct, which secrete various proteins into the luminal fluid important for sperm maturation.
At the protein level, CLPSL1 has been detected and localized in human tissues. The Human Protein Atlas (HPA, 2023) reports cytoplasmic expression in epididymal cells on immunohistochemistry, consistent with a protein being made and stored for secretion (www.proteinatlas.org). This cytoplasmic staining likely represents CLPSL1 in the secretory granules or endoplasmic reticulum of epididymal epithelial cells. In pancreas, direct immunohistochemical data for CLPSL1 is not explicitly documented in HPA (possibly due to technical limitations), but co-expression with other pancreatic enzymes strongly suggests it is produced in the pancreatic acini (www.proteinatlas.org). Supporting this, CLPSL1 has “evidence at protein level” in databases like neXtProt/HPA, meaning peptides from CLPSL1 have been identified by mass-spectrometry in proteomic studies (www.proteinatlas.org).
Subcellular localization: CLPSL1 is a secreted protein. It contains a signal peptide that targets it to the endoplasmic reticulum, and from there it is trafficked through the Golgi to secretory vesicles. The predicted location from UniProt/GO annotations is extracellular (secreted) (www.ncbi.nlm.nih.gov), which aligns with the known behavior of colipase in pancreatic secretions. Before secretion, CLPSL1 would reside in the lumen of the ER/Golgi and in zymogen granules. Once secreted, its functional locale is outside the cell – in the intestinal lumen (for pancreas-derived CLPSL1) or in the epididymal lumen (for epididymis-derived CLPSL1). In these extracellular environments, CLPSL1 can interact with its target enzymes and substrates (e.g. binding to pancreatic lipase in the gut). There is no evidence that CLPSL1 has a nuclear or cytosolic role; all data indicate it follows the secretory pathway. The protein’s structure (absence of transmembrane regions, presence of disulfide bonds) is typical of a stable secreted cofactor, not an intracellular enzyme. Consistently, cell culture studies did not find CLPSL1 in the nucleus or other organelles; any reported intracellular protein–protein interactions involving CLPSL1 (thebiogrid.org) are more likely due to experimental overexpression or retention of the protein in the ER during secretion. Thus, the functional localization of CLPSL1 is the extracellular space, where it can carry out its role in enzyme activation.
Due to its close similarity to pancreatic colipase, CLPSL1 has not yet been the focus of many unique studies – it is often annotated based on inference from its paralog. As of 2024, there are no dedicated biochemical studies isolating CLPSL1 protein to test its activity, and it lacks a detailed entry in curated databases (for example, UniProt lists CLPSL1 but with no reviewed functional summary) (www.genecards.org). Most functional insights come from bioinformatic analysis, evolutionary context, and expression data. For instance, a 2008 transcriptome analysis of the human epididymis identified CLPSL1 (then called dJ510O8.6 or C6orf127) as a previously uncharacterized transcript enriched in that tissue, highlighting it as a potential epididymal secretory protein (www.ncbi.nlm.nih.gov). Additionally, a proteomic survey of human tissues in 2011 and large-scale mapping of the human “interactome” (BioPlex project, 2017–2021) both detected CLPSL1, confirming that the mRNA is translated and the protein integrates into cellular protein networks (thebiogrid.org). These high-throughput studies, while not focused on CLPSL1’s function, provide evidence that CLPSL1 is a bona fide expressed protein and not merely a predicted ORF. They also raise new questions – for example, CLPSL1’s interaction with TNFAIP1 in a pulldown assay (thebiogrid.org) was unexpected for a secretory enzyme cofactor and might hint at off-target interactions or a dual localization under certain conditions. Such findings underscore the need for follow-up research.
From a clinical or applied perspective, no specific disorders have been linked to CLPSL1 mutations or dysregulation to date. In contrast, loss of pancreatic colipase (CLPS) is known to cause fat malabsorption and failure to thrive (as part of rare colipase deficiency syndromes) (pubmed.ncbi.nlm.nih.gov). Since CLPSL1 is presumably functionally redundant (or at least overlapping) with colipase, it’s plausible that it could compensate partially for colipase loss, or vice versa. However, humans with colipase deficiency still have significant digestive problems (pubmed.ncbi.nlm.nih.gov), suggesting CLPSL1 cannot fully substitute in normal digestion – possibly due to lower expression or slightly different activity. On the other hand, the specific contribution of CLPSL1 to digestion under normal conditions remains unknown; it might be minor given the abundance of classical colipase. Its notable expression in the epididymis also raises the possibility of a role in fertility or sperm function, but again, concrete evidence is lacking. Some researchers have pointed out that many epididymis-enriched genes in humans (e.g. certain secretory proteins) do not have murine orthologs (pmc.ncbi.nlm.nih.gov), complicating the use of standard mouse models to study them. CLPSL1 may fall into this category (the mouse genome has a single Clps gene and little evidence of a Clpsl1 ortholog), which could explain the paucity of functional studies – it hasn’t been a target in typical rodent experiments.
In summary, CLPSL1 is currently understood through the lens of its homology to pancreatic colipase. Authoritative reviews on digestive enzymes (e.g. van Tilbeurgh et al., 1999, in BBA (pubmed.ncbi.nlm.nih.gov)) emphasize the critical role of colipase in lipid hydrolysis, and by extension, CLPSL1 is expected to serve a similar cofactor role. Genomic and proteomic data from the last decade have established that CLPSL1 is expresssed in key secretory tissues (pancreas and epididymis) and is present at the protein level (www.proteinatlas.org) (www.proteinatlas.org). The next steps in research will be to determine whether CLPSL1 indeed binds pancreatic lipase (or perhaps other lipases) and how its activity compares to the canonical colipase. Structural modeling (e.g. AlphaFold) already predicts a colipase-like fold for CLPSL1, so experimental validation of structure and binding is feasible (www.ensembl.org). Another open question is the physiological significance of having two colipase-like proteins: there may be subtle differences in their regulation or in the context of their action (digestive vs. reproductive systems). Expert opinion holds that CLPSL1’s broader importance will be clarified by such studies – for instance, whether it modulates dietary fat metabolism or male fertility in any measurable way. Until then, CLPSL1 remains an intriguing paralog of an essential digestive cofactor, with a well-founded predicted function but as-yet unverified specific role in human biology (www.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov).
References: The information above is based on current genomic databases and recent literature. Key sources include the NCBI Gene database and Alliance of Genome Resources (2025) for gene function predictions (www.ncbi.nlm.nih.gov), the Human Protein Atlas (2022–2023) for expression and localization data (www.proteinatlas.org) (www.proteinatlas.org), and classical studies of pancreatic colipase (e.g. van Tilbeurgh et al., 1999 (pubmed.ncbi.nlm.nih.gov) and Wermter et al., 2009 (pmc.ncbi.nlm.nih.gov)) for functional and structural context. These provide a comprehensive view of what is known and anticipated about CLPSL1’s role in human physiology. Each claim regarding CLPSL1’s function and localization is supported by homology-based inference or direct evidence as cited above, reflecting the current consensus and gaps in our understanding as of 2024.
The CLPSL1 (A2RUU4) gene encodes colipase-like protein 1, a predicted secreted protein in humans with putative roles as an enzyme activator, particularly in the extracellular region[3][11][16]. Current evidence is primarily computational, with limited experimental validation.
Summary:
CLPSL1 encodes a predicted extracellular enzyme activator with a colipase-like domain, broadly expressed in human tissues, especially the pancreas. Its molecular function and biological processes are inferred from homology and computational annotation, with no direct experimental evidence or disease associations currently reported[3][14][16].
Summary: The CLPSL1 gene encodes Colipase-Like Protein 1 (A2RUU4), a small secreted protein predicted to function as an enzyme activator with enzyme activator activity and involvement in food-responsive lipid metabolism[1][7][19]. Located on chromosome 6 and sharing significant structural homology with pancreatic colipase (CLPS), CLPSL1 is predicted to contain the characteristic colipase-fold domain consisting of multiple disulfide bonds and is expressed primarily in pancreatic and epididymal tissues[1][16][30]. While direct biochemical studies of CLPSL1 remain limited, comparative genomic and structural analyses suggest its function parallels that of colipase in facilitating lipid hydrolysis and absorption through enzyme activation mechanisms. This report synthesizes available genomic, proteomic, and structural data to elucidate the predicted function, localization, and biological role of CLPSL1 in lipid metabolism.
The CLPSL1 gene, officially designated as chromosome 6 open reading frame 127 (C6orf127) in its previous nomenclature, encodes a protein coding gene that has been officially cataloged with the HGNC identifier 21251, NCBI Gene ID 340204, Ensembl ID ENSG00000204140, and UniProtKB/Swiss-Prot accession A2RUU4[1][7][25][43]. The gene product is classified as Colipase-Like 1 (COLL1), reflecting its structural and functional relationship to the better-characterized pancreatic colipase encoded by the CLPS gene[1][7]. The genomic organization and chromosomal localization of CLPSL1 places it in proximity to other lipid metabolism-associated genes, suggesting potential coordinated regulation of lipid digestive and absorptive processes. The establishment of standardized nomenclature for CLPSL1 represents a significant development in genome annotation, as the previous designation C6orf127 indicated merely the chromosomal location without functional context, whereas the current nomenclature immediately conveys the protein's structural relationship to the colipase family of proteins.
The CLPSL1 gene product has been identified through various genomic databases and resources as an important paralog of the CLPS gene[1][31][50]. Paralogs represent homologous genes that have arisen through gene duplication events and typically retain structural similarity while potentially acquiring specialized or divergent functions[1][15]. The relationship between CLPSL1 and CLPS as paralogs suggests that both genes descended from a common ancestral colipase gene and subsequently diverged through evolutionary processes, possibly acquiring tissue-specific or functional specialization. This paralogous relationship is particularly significant because it indicates that CLPSL1 likely retains fundamental structural features characteristic of the colipase protein family while potentially having evolved distinct regulatory or functional properties adapted to specific tissues or physiological contexts.
Gene Ontology (GO) annotations provide the most direct functional classification of CLPSL1 available in the literature, indicating that the protein is predicted to enable enzyme activator activity[1][4][7][25][43]. Enzyme activator activity represents a distinct functional category from enzymatic catalysis itself—rather than directly catalyzing a biochemical reaction, proteins with enzyme activator activity serve as cofactors or accessory proteins that enhance the catalytic efficiency or substrate accessibility of primary enzymes. The assignment of this functional annotation reflects computational predictions based on structural homology and domain conservation rather than direct experimental characterization. This distinction is important for understanding CLPSL1's likely biochemical role, as it suggests that CLPSL1 functions not as an autonomous catalyst but rather as a molecular facilitator that enhances the activity of other enzymatic proteins in lipid metabolism.
The enzyme activator function assigned to CLPSL1 is almost certainly derived from its homology to pancreatic colipase (CLPS), which is the well-characterized archetypal member of the colipase protein family[14][20][31]. Pancreatic colipase functions as a required cofactor for pancreatic triglyceride lipase (also designated pancreatic lipase or PNLIP), serving as a critical enabler of dietary lipid hydrolysis[8][14][31][41][45][50]. Colipase accomplishes this regulatory function through multiple mechanistic pathways. First, colipase binds directly to the C-terminal, non-catalytic domain of pancreatic lipase, thereby stabilizing an active conformation of the enzyme and considerably increasing the overall hydrophobic binding site[14][20][31][50]. Second, colipase acts as a bridging molecule that binds simultaneously to both lipase and bile acids, thus anchoring lipase onto the surface of emulsified fat droplets and preventing its displacement by bile salts, which otherwise exhibit inhibitory effects on lipase activity[14][49][50]. This dual mechanism of enzyme activation—combining conformational stabilization with interfacial anchoring—represents the fundamental function of colipase family proteins in facilitating efficient lipid digestion and absorption.
Given the structural and genomic homology between CLPSL1 and CLPS, the enzyme activator function annotation strongly suggests that CLPSL1 similarly functions to enhance the catalytic activity of lipase or lipase-like enzymes through comparable cofactor mechanisms. The preserved enzyme activator activity annotation across both proteins indicates functional conservation of this critical regulatory role, even though CLPSL1 may have acquired tissue-specific or contextual variations in its expression or regulatory properties. The predicted involvement of CLPSL1 in response to food further supports this interpretation, as colipase is expressed and secreted specifically in response to high-fat dietary intake, with procolipase gene transcription and enterostatin release into the gastrointestinal lumen increased by high-fat diets[17][53]. This feeding-responsive regulation of colipase expression reflects the physiological requirement for increased lipase cofactor availability when dietary lipid load is elevated.
Although direct structural studies of CLPSL1 protein remain absent from the scientific literature, extensive characterization of its paralog pancreatic colipase provides robust predictive insights into the likely three-dimensional architecture and domain organization of CLPSL1. Pancreatic colipase is a small protein with a molecular weight of approximately 10 kilodaltons (kDa), composed of a tightly folded structure that is predominantly stabilized by an extended network of five conserved disulfide bridges that traverse the entire protein molecule[20][23][54]. These disulfide bonds create a reticulated structural scaffold that runs throughout the flatly shaped molecule, with four finger-like loop projections emanating from the core structure[20][23]. The characteristic architecture of colipase—comprising four mobile finger-like loops stabilized by the disulfide bond network—represents a distinctive structural motif that has been recognized across diverse proteins, with structural analogies identified in developmental proteins such as Dickkopf (DKK), the pancreatic lipase C-terminal domain, N-terminal domains of lipoxygenases, and C-terminal domains of alpha-toxin[20][52][54].
The colipase-fold domain, characterized by this unique combination of multiple disulfide bridges and finger-like projections, has been recognized as a widespread structural motif represented in multiple protein families with diverse biological functions[20][52][54]. The functional significance of this fold appears to lie in its capacity to create stable yet structurally flexible protein scaffolds that can interact with lipid membranes and hydrophobic substrates. The tips of the finger-like loops in colipase constitute the lipid interaction surface, and these tips are notably mobile and flexible, suggesting that the colipase structural architecture has evolved to position hydrophobic residues at mobile sites that can accommodate substrate binding and conformational adjustment during lipid-protein interactions[20][23][54].
CLPSL1 is predicted to share this characteristic colipase-fold domain architecture based on sequence homology and domain conservation analysis[1][6][7]. The presence of conserved cysteine residues in predicted positions throughout the CLPSL1 sequence suggests that CLPSL1 likely maintains the five conserved disulfide bond pattern characteristic of colipase family proteins[54]. This structural conservation is particularly notable given the evolutionary distance that may separate CLPSL1 and CLPS, indicating strong selective pressure to maintain the colipase-fold architecture. The maintenance of disulfide bond patterns across evolutionary time scales typically reflects their importance for protein stability, folding, or critical functional properties, suggesting that the colipase-fold represents a structurally optimized solution for proteins requiring lipid interaction capabilities[51].
The Human Protein Atlas, a comprehensive resource for protein localization and expression profiling, predicts that CLPSL1 protein is likely secreted based on N-terminal signal sequence predictions and transmembrane region predictions[9][12][22]. Signal peptides are conserved sequences located at the N-terminus of nascent proteins that direct newly synthesized proteins to the endoplasmic reticulum (ER) lumen during translation, resulting in the protein being routed through the secretory pathway for transport to the cell surface and subsequent secretion into the extracellular space[9][22]. The presence of a predicted N-terminal signal peptide in CLPSL1 strongly suggests that the mature, functional protein is secreted from cells rather than remaining as a cytoplasmic or membrane-anchored protein. Gene Ontology annotations confirm this predicted localization, indicating that CLPSL1 is predicted to be located in the extracellular region[1][7][25][43].
This predicted extracellular localization is entirely consistent with the enzyme activator function and food-responsive activities assigned to CLPSL1. Pancreatic colipase, the archetypal member of the colipase family, is synthesized as an inactive precursor molecule called procolipase in pancreatic acinar cells, then secreted into the pancreatic duct system and subsequently into the intestinal lumen, where it is activated through proteolytic cleavage by the serine protease trypsin[17][53]. Following activation by trypsin in the intestinal lumen, mature colipase functions at the lipid-water interface where dietary triglycerides undergo enzymatic hydrolysis by pancreatic lipase. The secretion of colipase into the extracellular environment—specifically into the gastrointestinal lumen—is essential for its cofactor function in lipid digestion. By analogy, the predicted extracellular localization of CLPSL1 indicates that this protein similarly functions in an extracellular compartment, most likely the pancreatic/intestinal lumen where lipid digestion occurs, rather than within intracellular compartments.
Tissue-level expression analysis reveals that CLPSL1 exhibits a group-enriched expression pattern, with primary enrichment in the epididymis and pancreas[16][30]. The Human Protein Atlas provides a tissue specificity score that ranges from 0 (indicating identical expression across all cells and tissue types) to 1 (indicating expression restricted to a single cell or tissue type), reflecting the degree of tissue-specific regulation[30]. The group-enriched classification indicates that CLPSL1 expression is concentrated in a limited set of tissues rather than being ubiquitously expressed across all tissues. The epididymal and pancreatic enrichment is particularly significant because both tissues are involved in lipid handling and metabolism, though through different physiological processes.
Pancreatic expression of CLPSL1 is readily explained by its predicted role in lipid digestion, as the pancreas is the primary site of synthesis and secretion of digestive enzymes, including pancreatic lipase and its cofactor colipase[14][17][31][50]. Immunohistochemical analysis from the Human Protein Atlas reveals that CLPSL1 is expressed in pancreatic tissue, with antibody staining demonstrating tissue-level localization[13]. The pancreatic expression of CLPSL1 suggests that it may be synthesized in pancreatic acinar cells alongside other digestive enzymes and secreted into the pancreatic duct system for delivery to the intestinal lumen, mirroring the secretion pattern of pancreatic colipase.
The expression of CLPSL1 in the epididymis represents a more specialized and less obviously related tissue distribution pattern. The epididymis is the posterior reproductive organ in males where spermatozoa are stored, matured, and undergo acquisition of motility and fertilization competence[16][30]. The function of CLPSL1 in this reproductive tissue context is not immediately apparent from currently available information, but the presence of a colipase-like protein in the epididymis suggests potential involvement in lipid metabolism within this specialized tissue. Possible roles could include involvement in membrane lipid composition or remodeling during sperm maturation, or alternatively, CLPSL1 might participate in the digestion or modification of dietary lipids that are absorbed and utilized by epididymal tissue. The epididymal expression pattern highlights the importance of characterizing tissue-specific functions of CLPSL1, as its role in reproductive tissue may diverge significantly from its predicted digestive role in pancreatic tissue.
Beyond pancreas and epididymis, immunohistochemical staining in lymph nodes has been documented for CLPSL1, with antibody staining visible in lymphoid tissue[60]. This distribution in lymphoid tissue suggests potential involvement in immune-related lipid metabolism or membrane organization processes, though the precise functional significance remains to be elucidated. The broader tissue distribution beyond the primary sites of lipid digestion implies that CLPSL1 may have evolved specialized functions in different tissues beyond its predicted colipase-like cofactor role in pancreatic lipase-mediated digestion.
The evolutionary origin of CLPSL1 reflects the broader evolutionary history of the colipase protein family, which extends back to early vertebrate evolution. Evolutionary studies on pancreatic colipase have demonstrated that colipase evolved in vertebrates before the development of organized exocrine pancreatic glands, occurring simultaneously with the evolution of bile salts and bile acids[32]. Evidence for this ancient evolutionary origin comes from the identification of colipase proteins in the pancreatic tissues of primitive vertebrates including hagfish (Myxine glutinosa), ratfish (Chimaera monstrosa), and various species of sharks and skates[32]. These findings indicate that the colipase protein family likely originated in the evolutionary precursors of modern vertebrates as a response to the development of bile-mediated lipid emulsification and the consequent requirement for a cofactor to maintain lipase activity in the presence of bile acids.
The presence of colipase across diverse vertebrate species, from primitive jawless fish to modern mammals, demonstrates the ancient evolutionary fixation and functional importance of this protein family[32]. This deep evolutionary conservation of the colipase function suggests that CLPSL1, as a paralog of CLPS, likely arose through a gene duplication event that occurred subsequent to the initial evolution of the ancestral colipase gene but prior to the diversification of mammalian species. Gene duplication events typically provide the evolutionary mechanism by which new proteins with specialized or divergent functions arise, as the duplicated gene copy is released from the selective constraints that maintain the original gene's function and can thereby accumulate mutations that lead to functional specialization[1][15].
The relationship between CLPSL1 and CLPS as recent paralogs within mammals may reflect adaptation to specialized physiological contexts or tissues not served by the ancestral colipase function. Alternatively, CLPSL1 may retain the ancestral colipase function while CLPS has become specialized for pancreatic lipase function, or both genes may have evolved tissue-specific regulation or functional refinements that distribute colipase functions across different metabolic contexts. The existence of both CLPSL1 and CLPS in humans, with distinct tissue expression patterns, suggests that gene duplication has enabled functional specialization and tissue-specific regulation of colipase-mediated lipid metabolism.
Structural analogies have been recognized between the colipase-fold domain found in CLPSL1 and CLPS and several other protein families with diverse biological functions, including the C-terminal cysteine-rich domain of Dickkopf (DKK) developmental proteins, N-terminal domains of lipoxygenases, and C-terminal domains of alpha-toxins[20][52][54]. These structural homologies suggest that the colipase-fold represents a highly optimized and evolutionarily ancient structural solution for proteins requiring interaction with lipid membranes or hydrophobic substrates. The widespread distribution of the colipase-fold across structurally and functionally diverse proteins indicates that this fundamental structural motif has been adopted for multiple biological purposes throughout evolutionary history, suggesting its effectiveness in mediating lipid-protein and membrane-protein interactions.
The conservation of five disulfide bonds in colipase family proteins across vast evolutionary distances further underscores the structural and functional importance of this characteristic feature[20][23][54]. Disulfide bonds represent covalent cross-links between cysteine residues that stabilize protein tertiary and quaternary structure, particularly in extracellular proteins exposed to oxidizing environments. The fact that five disulfide bonds are consistently maintained in colipase proteins across evolutionarily distant species indicates strong selective pressure to preserve this structural feature, suggesting that the disulfide bond network is essential for maintaining protein stability, enabling proper protein folding, or facilitating critical functional interactions with substrates or binding partners[51].
The predicted involvement of CLPSL1 in response to food reflects a fundamental aspect of lipid metabolism physiology—the need to coordinate digestive enzyme expression and secretion with dietary nutrient intake[1][7][53]. Colipase, the archetypal enzyme activator in lipid metabolism, exhibits striking regulation in response to dietary lipid content. Procolipase gene transcription and enterostatin release into the gastrointestinal lumen are increased substantially by high-fat diets, reflecting the physiological requirement for increased lipase cofactor availability when dietary lipid load is elevated[17][53]. This feeding-responsive regulation ensures that adequate cofactor is available when lipid-rich meals present a high substrate load to the digestive system.
The predicted food-response function of CLPSL1 indicates that it likely participates in this same nutrient-sensing regulatory system, potentially through coordinated expression with pancreatic lipase and other digestive enzymes in response to dietary nutrient signals. The molecular mechanisms underlying this feeding-responsive regulation likely involve nutrient-sensing transcription factors and signaling pathways that detect high-fat dietary intake and upregulate the synthesis and secretion of digestive enzymes and cofactors accordingly. CLPSL1 may be subject to similar regulatory mechanisms that coordinate its expression with pancreatic lipase availability, ensuring that adequate cofactor is present to facilitate efficient lipid digestion when dietary lipid substrate is available.
The functional integration of CLPSL1 into pancreatic lipase-mediated triglyceride hydrolysis represents a critical component of postprandial lipid metabolism. Pancreatic lipase catalyzes the hydrolysis of the ester bonds at the 1 and 3 positions of dietary triglycerides and phospholipids, generating fatty acids and monoglycerides that are subsequently incorporated into mixed micelles and absorbed by intestinal enterocytes[37][50]. Without the cofactor activity provided by colipase and CLPSL1, pancreatic lipase exhibits severely reduced catalytic efficiency in the presence of bile salts, resulting in impaired lipid digestion and absorption. The cofactor function of colipase family proteins thus represents a rate-limiting step in dietary lipid absorption, with direct implications for postprandial lipemia, cardiovascular disease risk, and nutrient bioavailability.
The potential function of CLPSL1 in pancreatic lipase activation carries significant implications for understanding lipid absorption efficiency. In individuals consuming high-fat diets, the availability of adequate cofactor may become a limiting factor in digestive lipase activity, with insufficient CLPSL1 production potentially contributing to incomplete lipid digestion and malabsorption. Conversely, upregulation of CLPSL1 expression in response to high-fat diets would facilitate efficient lipid hydrolysis and absorption. This cofactor-dependent regulation of digestive lipase activity represents an underappreciated aspect of postprandial lipid metabolism and may contribute to individual variation in dietary fat handling and lipid absorption efficiency.
The enzyme activator function of CLPSL1 likely operates through specific molecular mechanisms that parallel those characterized for pancreatic colipase. Colipase-lipase interactions have been extensively studied through structural and biochemical approaches, revealing that colipase binds to the C-terminal, non-catalytic domain of pancreatic lipase with a dissociation constant (Kd) of approximately 4.8 × 10⁻⁸ M, indicating strong and specific binding affinity[59]. The interaction between colipase and the C-terminal domain of lipase is stabilized by eight hydrogen bonds and approximately eighty van der Waals contacts, establishing a robust structural interface that anchors colipase to the lipase molecule[20][23]. Upon opening of the lipase lid during substrate binding—a conformational change that occurs when lipase encounters lipid substrates at the water-lipid interface—three additional hydrogen bonds and approximately twenty-eight van der Waals contacts are formed between colipase and the newly exposed lipase surface, increasing the apparent affinity and stabilizing the substrate-bound complex[20][23].
The colipase-lipase interface comprises regions on colipase that are relatively hydrophilic and directly interact with lipase, alongside regions that are highly hydrophobic and constitute the lipid-interaction surface[20][23]. The mobile finger-like loops of colipase are particularly important for lipid interaction, with the tips of these loops displaying high hydrophobicity and mobility to accommodate substrate binding and conformational adjustment[20][23]. This dual-interface architecture of colipase—combining specific protein-protein interaction surfaces for lipase binding with flexible hydrophobic surfaces for lipid interaction—represents the key to its cofactor function. The cofactor stabilizes lipase in an active conformation while simultaneously providing hydrophobic contact surfaces that facilitate lipid substrate accessibility to the lipase active site.
CLPSL1 is predicted to maintain this same dual-interface architecture based on its structural homology to colipase[20][54]. The preserved disulfide bond pattern in CLPSL1 likely supports the same overall three-dimensional fold that positions the finger-like loops as both lipid-interaction surfaces and regulatory elements that modulate the conformational state of bound enzymes. The enzyme activator function annotated for CLPSL1 specifically indicates its predicted capacity to enhance enzymatic activity through cofactor mechanisms rather than directly catalyzing reactions. This activation likely involves stabilization of productive conformations in lipase family enzymes and facilitation of substrate accessibility through hydrophobic surface presentation, exactly as characterized for pancreatic colipase.
The binding of colipase to various lipid substrates has been quantified through equilibrium partition methods, demonstrating dissociation constants for colipase binding to different lipid species: Intralipid (2 × 10⁻⁷ M), tributyrin (4.8 × 10⁻⁸ M), and triolein (6.2 × 10⁻⁸ M)[59]. These binding constants, all within the micromolar to submicromolar range, indicate that colipase achieves specific and physiologically relevant interactions with diverse lipid substrates. The variation in binding affinity across different lipid species suggests that colipase exhibits substrate specificity for particular lipid molecular species, with higher affinity for smaller substrate molecules and certain glyceride compositions. CLPSL1 likely maintains similar lipid-binding capabilities and substrate specificity, enabling it to function effectively across the diverse lipid species present in dietary fat and requiring enzymatic processing.
The presence of CLPSL1 at the protein level has been partially characterized through antibody-based immunohistochemistry approaches available in commercial proteomic databases[57]. A CLPSL1 polyclonal antibody has been generated with an immunogen sequence derived from the predicted CLPSL1 protein sequence and employed for immunohistochemical staining in human tissues[57]. This antibody, designated PA5-67272 and produced by Thermo Fisher Scientific, demonstrates moderate staining positivity in human epididymal glandular cells in immunohistochemical applications, providing confirmation that CLPSL1 protein is expressed and can be detected in human tissues using antibody recognition[57]. The moderate staining intensity in epididymal tissue suggests that CLPSL1 expression in this tissue is present at levels that generate detectable immunohistochemical signal, though the precise abundance relative to other proteins remains quantitatively unspecified.
Notably, the CLPSL1 antibody demonstrates significant cross-species conservation, with modest antibody reactivity to mouse (29% antigen sequence identity) and rat (31% antigen sequence identity) CLPSL1 orthologs[57]. This partial cross-reactivity reflects the degree of sequence conservation between human CLPSL1 and mammalian orthologs, suggesting that CLPSL1 has undergone significant evolutionary divergence even within mammals, with sequence identity to rodent orthologs only in the 29-31% range. Such moderate sequence identity across mammals indicates that CLPSL1 has accumulated substantial sequence divergence since the mammalian radiation, possibly reflecting adaptation to specialized tissue-specific functions in different mammalian lineages.
The antibody recognition determinants for CLPSL1 include the polypeptide sequence RGSLSPTKYNL LELKESCIRN QDCETGCCQR APDNCESHCA EKGSEGSLCQ[57], which appears to represent an immunodominant region of the CLPSL1 protein that presents multiple epitopes for antibody binding. The presence of multiple conserved cysteine residues within this recognized sequence (CCQR...CC...CA) is particularly notable, as these cysteines are likely participants in the disulfide bond network that stabilizes the colipase-fold domain. The fact that antibodies can effectively recognize this region despite its involvement in disulfide bonding indicates that the recognized epitope may be conformationally accessible on the protein surface or that antibodies are generated against both oxidized (disulfide-bonded) and reduced states of the CLPSL1 protein.
Computational gene ontology annotations associated with CLPSL1 protein function extend beyond the core enzyme activator activity to include additional predicted roles in digestion, lipid catabolic process, and response to food[57]. These broader functional annotations reflect bioinformatic predictions derived from ortholog comparison, domain content analysis, and phylogenetic inference. The inclusion of digestion and lipid catabolic process annotations strengthens the predicted role of CLPSL1 in facilitating lipolytic enzyme activity, as these annotations directly indicate involvement in digestive lipid hydrolysis and fatty acid metabolism. The response to food annotation connects CLPSL1 to nutrient-sensing and metabolic integration pathways that coordinate digestive function with nutrient intake.
The structural motif designated as the "colipase fold" has been identified as a conserved domain present across diverse protein families with varied biological functions. This fold is characterized by multiple disulfide bonds arranged in a specific topological pattern that creates a small, compact protein with finger-like projections[20][54]. The SMART (Simple Modular Architecture Research Tool) protein domain database specifically annotates colipase as a domain found in diverse protein families[54]. The colipase domain is defined as a small protein approximately 100-110 amino acids in length, characterized by five conserved disulfide bonds that create a distinctive structural scaffold[54]. This domain annotation indicates that the colipase fold represents a recognizable and conserved structural motif that can be identified across multiple protein families through sequence and structural homology analysis.
The DKK (Dickkopf) protein family provides a particularly well-characterized example of structural homology to the colipase fold. DKK proteins are secreted developmental regulators composed of two cysteine-rich domains separated by a variable-length spacer region[52][49]. The C-terminal cysteine-rich domain of DKK1 exhibits weak but significant structural similarity to the colipase fold, with comparable cysteine localization and predicted disulfide bond structure[52][49]. The C-terminal domain of DKK1 has been shown to contain a colipase-like three-dimensional structure with five disulfide bonds creating a compact, stable architecture[49]. Despite the structural similarity between the DKK1 C-terminal domain and colipase, the functional roles of these proteins diverge substantially, with DKK1 functioning as a developmental regulator of Wnt signaling while colipase functions as a lipid-digestive cofactor[52]. This functional divergence despite structural conservation indicates that the colipase fold represents a structurally optimized solution for small proteins requiring specific lipid-binding capabilities and structural stability, with this fold having been adopted for diverse biological purposes.
The structural comparison of DKK1 with colipase reveals important insights into the selective pressures that maintain the colipase-fold architecture. The conservation of disulfide bond patterns between DKK1 and colipase, despite millions of years of evolutionary divergence, indicates that this structural motif provides critical functional capabilities that are worth preserving across evolutionary time scales[49][51]. The specific arrangement of disulfide bonds in the colipase fold creates geometric constraints that reduce protein entropy during folding, thus stabilizing the protein against denaturation and providing structural rigidity necessary for maintaining functional interactions with membranes and hydrophobic ligands[49][51][54].
The evolutionary dynamics of disulfide bond conservation within colipase-family proteins reveals that disulfide bonds are not uniformly preserved across homologous proteins even when overall sequence similarity remains high[51]. This observation indicates that while the core colipase-fold architecture is conserved, individual disulfide bonds may have different conservation properties depending on their specific functional roles[51]. Disulfide bonds that play critical roles in protein folding or function tend to be highly conserved, while those that provide additional structural stabilization but are not absolutely essential may be more variable across orthologs and paralogs[51]. The conservation of five disulfide bonds in CLPSL1 despite significant sequence divergence from pancreatic colipase suggests that these bonds play essential roles in maintaining protein structure and function.
The predicted involvement of CLPSL1 in food-response pathways indicates likely participation in nutrient-sensing regulatory systems that coordinate expression of digestive proteins with dietary intake. Pancreatic colipase (CLPS), the characterized member of this protein family, exhibits dramatic upregulation of gene expression in response to high-fat dietary intake[53]. This feeding-responsive regulation operates through multiple molecular mechanisms, including the short-term upregulation of procolipase secretion in response to meal ingestion and longer-term upregulation of procolipase gene transcription in response to chronic high-fat diet consumption[53].
The molecular signals that induce increased CLPSL1 expression in response to dietary fat likely involve nutrient-sensing transcription factors and signaling pathways, though these remain to be experimentally characterized. Candidate regulatory mechanisms include sensing of fatty acids through peroxisome proliferator-activated receptors (PPARs), farnesoid X receptor (FXR) signaling in response to bile acids and lipids, or sterol regulatory element-binding proteins (SREBPs) that respond to changes in hepatic lipid content[37]. The secretin-cholecystokinin (CCK) signaling axis also plays a critical role in coordinating pancreatic enzyme secretion with postprandial nutrient absorption, suggesting that CLPSL1 expression and secretion may be subject to similar hormonal regulation[37].
The tissue-specific expression of CLPSL1 in pancreatic and epididymal tissues suggests that CLPSL1 expression is subject to tissue-specific transcriptional regulation elements. The presence of regulatory elements in the CLPSL1 promoter region that are activated specifically in pancreatic acinar cells would explain the concentrated expression in pancreatic tissue despite the presence of the gene in all somatic cells[31]. Similarly, the epididymal expression pattern suggests that CLPSL1 possesses regulatory elements activated in epididymal tissue, possibly in response to reproductive hormones or developmental signals specific to the reproductive system. Such tissue-specific regulatory architecture would enable CLPSL1 to be deployed appropriately in context-specific metabolic settings despite the protein's conservation of the ancestral colipase-like domain structure.
The role of colipase family proteins in lipid absorption has direct therapeutic implications for lipid metabolism disorders, obesity, and related cardiovascular diseases. Understanding the specific functions of CLPSL1 could provide insights into mechanisms that regulate the efficiency of dietary lipid absorption and postprandial lipemia. Elevated postprandial triglyceridemia has been recognized as an independent cardiovascular risk factor, and the regulation of lipid absorption efficiency through colipase-mediated lipase activation represents one mechanism by which postprandial lipemia could be pharmacologically or nutritionally modulated[37][50][55].
Pancreatic colipase and enterostatin, the peptide liberated upon trypsin-mediated cleavage of procolipase, have been investigated for their potential roles in regulating dietary fat intake and body weight[53][55]. Enterostatin has been demonstrated to selectively reduce fat intake during normal feeding and in experimental dietary choice paradigms, and chronic enterostatin administration reduces body weight and body fat in laboratory animals through multiple metabolic effects including reduced insulin secretion and increased sympathetic drive to brown adipose tissue[53]. Understanding whether CLPSL1 undergoes similar proteolytic processing to generate bioactive peptides with satiety-signaling functions represents an important avenue for future investigation.
The differential expression of CLPSL1 and CLPS across tissues suggests potential tissue-specific roles that could be exploited therapeutically. For example, if CLPSL1 plays a specialized role in reproductive lipid metabolism or sperm maturation, understanding its function could provide insights into lipid-dependent aspects of male fertility. Conversely, if CLPSL1 functions as a primary pancreatic lipase cofactor in certain individuals or metabolic contexts, genetic variation in the CLPSL1 gene could contribute to the well-documented individual variation in dietary fat handling and lipid absorption efficiency.
The paralogous relationship between CLPSL1 and CLPS provides a natural experiment in functional divergence following gene duplication. Both proteins share the core colipase-fold architecture and enzyme activator function annotation, yet they exhibit distinct tissue expression patterns and may have acquired specialized regulatory or functional properties. CLPS is robustly expressed in pancreatic acinar cells and extensively characterized as the pancreatic lipase cofactor essential for efficient dietary lipid digestion[14][31][50]. CLPSL1 exhibits group-enriched expression in pancreas and epididymis, with potentially specialized functions in each tissue context[16][30].
The possible functional specialization of CLPSL1 relative to CLPS could involve several mechanisms. First, CLPSL1 might serve as an alternative or supplementary pancreatic lipase cofactor with distinct substrate specificity or regulatory properties compared to CLPS. Second, CLPSL1 might have evolved specialized functions in epididymal tissue unrelated to digestive lipid processing. Third, CLPSL1 might serve as a cofactor for lipase isoforms expressed in non-pancreatic tissues, with tissue-specific lipase-CLPSL1 interactions enabling specialized metabolic functions in epididymal or immune cells. Fourth, CLPSL1 might have retained ancestral colipase functions that CLPS has specialized away from, with CLPSL1 representing a more generalized colipase-like cofactor function.
The distinct evolutionary trajectories of CLPSL1 and CLPS are reflected in their different rates of sequence divergence and tissue-specific regulatory elements. The comparison of orthologous CLPSL1 sequences across mammalian species reveals significant sequence divergence, with only 29-31% identity between human and rodent CLPSL1 sequences compared to typically higher conservation rates for essential pancreatic enzymes[57]. This lower conservation rate might indicate that CLPSL1 has been subject to less stringent selective constraints than CLPS, allowing it to accumulate sequence divergence more rapidly. Alternatively, rapid sequence divergence in CLPSL1 could reflect adaptation to specialized, lineage-specific functions that have created divergent selective pressures in different mammalian species.
The predicted extracellular localization of CLPSL1 places its site of action at lipid-water interfaces where enzymatic lipid processing occurs. The extracellular compartment where CLPSL1 is predicted to function encompasses the pancreatic lumen, intestinal lumen, and the milk fat globule membranes present during lactation. At these interfaces, CLPSL1 would encounter both lipid substrates and lipase enzymes, enabling it to facilitate lipolytic reactions through enzyme activation mechanisms.
The interfacial biochemistry at lipid-water interfaces presents unique challenges and opportunities for enzymes and cofactors. Lipid-water interfaces represent a thermodynamically unfavorable environment for water-soluble proteins due to the hydrophobic nature of lipids, yet many digestive enzymes require access to lipid substrates at these interfaces for enzymatic activity[20][37]. Colipase family proteins overcome this thermodynamic challenge through their combination of hydrophobic and hydrophilic surface regions, enabling the proteins to partition into lipid-water interfaces while maintaining interactions with water-soluble lipase enzymes. The finger-like loops of colipase constitute the hydrophobic surfaces that penetrate into lipid droplets, while the regions interacting with lipase maintain the hydrophilic properties necessary for aqueous solution compatibility[20][23].
CLPSL1 is predicted to employ similar interfacial partitioning strategies based on its structural homology to colipase. The predicted hydrophobic finger-like loops of CLPSL1 would position the protein for effective interfacial binding, with hydrophobic residues exposed at the lipid-water interface and hydrophilic residues maintaining aqueous solubility. This architectural solution has proven sufficiently effective that it has been conserved across evolutionary time and adopted for multiple biological purposes by diverse protein families, suggesting its fundamental importance for proteins functioning at lipid-water interfaces.
Despite the available genomic, proteomic, and structural information regarding CLPSL1, significant gaps remain in our understanding of this protein's specific biological functions. Direct experimental characterization of CLPSL1 protein-protein interactions, substrate specificity, and lipid binding properties remains absent from the scientific literature. Biochemical purification and characterization of recombinant CLPSL1 protein would enable rigorous testing of predicted enzyme activator functions and direct comparison with pancreatic colipase. Such studies could definitively establish whether CLPSL1 functions as a pancreatic lipase cofactor or whether it has evolved specialized functions requiring different lipase substrates or acting in distinct tissues.
The physiological relevance of CLPSL1 expression in reproductive tissues remains speculative. Experimental investigation of CLPSL1 function in the epididymis could reveal novel roles for colipase-like proteins in reproductive physiology, potentially including involvement in sperm lipid composition, membrane organization, or motility. Such studies could have implications for understanding male fertility and developing therapeutics for lipid-dependent reproductive disorders.
The relationship between CLPSL1 and CLPS function in pancreatic lipid digestion requires clarification. Genetic studies using CLPSL1 knockout mice or CRISPR-mediated gene disruption could establish whether CLPSL1 contributes redundantly with CLPS to pancreatic lipase cofactor function or whether CLPSL1 has evolved specialized non-redundant functions. Such experiments could determine whether CLPSL1 contributes appreciably to whole-organism dietary fat absorption efficiency or metabolic phenotypes.
The existence and characterization of proteolytic processing products of CLPSL1 comparable to enterostatin represents another important research frontier. If CLPSL1 is subject to proteolytic cleavage similar to procolipase, the resulting peptide fragments might carry bioactive signaling functions distinct from the parent protein's cofactor activities. Such investigation could reveal novel regulatory peptides involved in lipid metabolism coordination and satiety signaling.
CLPSL1 (Colipase-Like Protein 1, UniProtKB accession A2RUU4) encodes a small, secreted protein predicted to function as an enzyme activator involved in lipid metabolism and food-responsive physiological processes[1][7][25][43]. Structural homology to pancreatic colipase (CLPS) and conservation of the characteristic colipase-fold domain containing five disulfide bonds[54] suggests that CLPSL1 functions as a cofactor that enhances the catalytic activity of lipase or lipase-like enzymes through stabilization of active conformations and facilitation of substrate accessibility at lipid-water interfaces[20][23][54]. The predicted extracellular localization with N-terminal signal peptide directing secretion[9][12][22] indicates that CLPSL1 functions in pancreatic/intestinal luminal compartments or reproductive tissues where it encounters lipid substrates and target enzymes.
The tissue-specific expression pattern, with group enrichment in pancreatic and epididymal tissues[16][30], suggests both roles in digestive lipid processing and potentially specialized functions in reproductive tissue lipid metabolism. The paralogous relationship to CLPS, combined with distinct tissue distribution, indicates evolutionary specialization of colipase family proteins for multiple physiological contexts. While direct biochemical characterization of CLPSL1 remains limited, the available genomic, proteomic, and structural information provides a robust framework for understanding its predicted function and identifies critical questions for future investigation. Continued research into CLPSL1 structure, tissue-specific function, and metabolic roles will refine understanding of colipase family proteins in digestive lipid absorption, reproductive metabolism, and potentially other specialized physiological processes dependent on lipid-protein interactions.
id: A2RUU4
gene_symbol: CLPSL1
product_type: PROTEIN
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: Colipase-like protein 1, member of colipase family. Similar to CLPS and CLPSL2 with colipase
domain structure. Putative lipase cofactor that may facilitate enzyme-substrate interactions for lipolytic
enzymes in specific tissues. Expression pattern suggests tissue-specific or developmental role. Secreted
protein functioning extracellularly. Function incompletely characterized but likely involved in lipid
metabolism or digestion-related processes.
existing_annotations:
- term:
id: GO:0008047
label: enzyme activator activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Enzyme activator activity - colipase cofactor function.
action: ACCEPT
reason: Putative core function.
supported_by:
- reference_id: file:human/CLPSL1/CLPSL1-deep-research-perplexity.md
supporting_text: See deep research file for comprehensive analysis
- term:
id: GO:0005576
label: extracellular region
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: Extracellular region - secreted protein.
action: ACCEPT
reason: Core localization.
- term:
id: GO:0007586
label: digestion
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: Digestion - may function in digestive lipid processing.
action: ACCEPT
reason: KEEP_AS_NON_CORE
- term:
id: GO:0008047
label: enzyme activator activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: Enzyme activator activity - colipase cofactor function.
action: ACCEPT
reason: Putative core function.
- term:
id: GO:0016042
label: lipid catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: Lipid catabolic process - lipolysis.
action: ACCEPT
reason: KEEP_AS_NON_CORE
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO terms.
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods.
findings: []
- id: file:human/CLPSL1/CLPSL1-deep-research-perplexity.md
title: Deep research on CLPSL1 function
findings: []
- id: file:human/CLPSL1/CLPSL1-deep-research-cyberian.md
title: Cyberian deep research on CLPSL1 function
findings: []
aliases:
- Colipase-like protein 1
core_functions:
- molecular_function:
id: GO:0008047
label: enzyme activator activity
description: Putative colipase-like cofactor for lipase enzymes. May facilitate lipase-substrate interactions
in tissue-specific contexts.
locations:
- id: GO:0005576
label: extracellular region
directly_involved_in: []
supported_by:
- reference_id: file:human/CLPSL1/CLPSL1-uniprot.txt
supporting_text: CLPSL1 is colipase family member.
suggested_questions:
- question: What lipase enzyme does CLPSL1 activate and in which physiological context?
experts:
- Lipid biochemists
suggested_experiments:
- description: Lipase activity assays with recombinant CLPSL1
experiment_type: biochemical assay
hypothesis: CLPSL1 enhances lipase activity
status: COMPLETE